Alloreactive Haploidentical Natural Killer (NK) Cells With Busulfan and Fludarabine/ATG
Status:
Completed
Trial end date:
2014-11-01
Target enrollment:
Participant gender:
Summary
The goal of this clinical research study is to learn if giving a kind of immune cell called
natural killer (NK) cells after chemotherapy will improve the response to a stem cell
transplant in patients with CML. The safety of this treatment will also be studied.